Quarterly Net Profit at Rs. 75.92 crore in December 2024 down 2.13% from Rs. 77.57 crore in December 2023. EBITDA stands at ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Concord Biotech reported that its consolidated net profit declined 2.19 percent to Rs 75.9 crore in the December 2024 quarter. Overall, the trend remains in favour of bears, given the negative ...

Concord Biotech shares dropped 16% to Rs 1,777.7 on Friday after the company reported a 2.1% year-on-year (YoY) decline in consolidated net profit to Rs 75.92 crore in Q3 FY25, compared to Rs 77. ...

Investment in 26% equity share capital in Clean Max, renewable energy aligns with the Company's commitment to sustainability and it's focused efforts to address environmental challenges. By ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 scheduled on 6th March, 2025 ...

Concord Biotech Ltd - Board Meeting Outcome for TO Make INVESTMENT IN M/S CLEAN MAX EVERGLADES PVT LTD FOR INSTALLATION OF HYBRID RENEWABLE ENERGY PLANT To Invest in M/s Clean Max Everglades Private ...